Home » UPC decisions » Central Division » Paris Central Division » CD Paris, December 18, 2024, decision in revocation action, UPC_CFI_454/2023

CD Paris, December 18, 2024, decision in revocation action, UPC_CFI_454/2023

4 min Reading time

Key takeaways

Even if a standstill provision requiring pre-suit notification is breached, this does not affect the Court’s jurisdiction or the admissibility of the action. The Court emphasized that access to justice is a fundamental right (Art. 47 of the Charter of Fundamental Rights of the EU), but that such a breach may have contractual implications.

The Court highlighted again the principle of ‘front-loaded’ proceedings by excluding late-filed prior art (documents ‘Menot’ and ‘Lieberman’) and invalidity arguments. This emphasizes the importance of Rules 13 and 44 RoP, requiring parties to present their complete case early on for procedural efficiency and fairness.

The Court rejected the added matter objection, finding that the disputed feature (feature 1.5) was sufficiently disclosed in the initial application, thus complying with Article 123(2) EPC. Particularly, the Court held that feature 1.5, which was introduced into the claim and another feature, which was ommited, were “not related one to the other” (mn. 54) so that the intermediate generalization was deemed admissible.

‘Diaz’ describes a medication delivery system with a flexible reservoir and a pump assembly. The Court identified that ‘Diaz’ did not disclose feature 1.3iii, as the figures showed a gap between the flexible reservoir and the rigid structure, indicating no limitation on the reservoir’s expansion. The Court also noted that ‘Robertson’, which relates to a container for solid medicaments, did not provide any suggestions to modify ‘Diaz’ to include the missing features. The combination of ‘Diaz’ and ‘Robertson’ was deemed insufficient to affect the inventive step of claim 1.

The Court reiterated that neither ‘Glejboel’, ‘Diaz’, nor ‘Robertson’ disclosed feature 1.3iii. Consequently, the combination of these documents could not affect the inventive step of claim 1.

Division

Central Division Paris

UPC number

UPC_CFI_454/2023

Type of proceedings

Decision in revocation action

Parties

Tandem Diabetes Care Europe B.V., Tandem Diabetes Care, Inc.
vs.
Roche Diabetes Care GmbH

Patent

EP 2 196 231 B1

Body of legislation / Rules

Article 47 of the Charter of Fundamental Rights of the European Union

Rule 13 RoP

Rule 19 (1) (b) RoP

Rule 44 RoP

Rule 48 RoP

Rule 333 RoP


Was the article helpful?


Categories


Tags

Stay in the loop

Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.

* = Required field